Affiliation:
1. Stanford Immunology Program, School of Medicine, Stanford University, 269 Campus drive, Stanford CA 94305-5174, United States
2. The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Henrietta Szold St. 8, POB 1589, Safed, Israel
Abstract
Backbone-cyclized peptides and peptidomimetics integrate the biological activity and pharmacological
features necessary for successful research tools and therapeutics. In general, these structures
demonstrate improved maintenance of bioactive conformation, stability and cell permeability compared
to their linear counterparts, while maintaining support for a variety of side chain chemistries. We explain
how backbone cyclization and cycloscan techniques allow scientists to cyclize linear peptides with retained
or enhanced biological activity and improved drug-like features. We discuss head-to-tail (Cterminus
to N-terminus), building unit-to-tail, building unit-to-side chain, building unit-to-building unit,
and building unit-to-head backbone cyclization, with examples of building blocks, such as Nα-(ω-
thioalkylene), Nα-(ω-aminoalkylene) and Nα-(ω-carboxyalkylene) units. We also present several methods
for recombinant expression of backbone-cyclized peptides, including backbone cyclic peptide synthesis
using recombinant elements (bcPURE), phage display and induced peptidyl-tRNA drop-off.
Moreover, natural backbone-cyclized peptides are also produced by cyanobacteria, plants and other organisms;
several of these compounds have been developed and commercialized for therapeutic applications,
which we review. Backbone-cyclized peptides and peptidomimetics comprise a growing share of
the pharmaceutical industry and will be applied to additional problems in the near future.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献